Correlation Between Exelixis and Hepion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Exelixis and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exelixis and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Exelixis and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Hepion Pharmaceuticals.

Diversification Opportunities for Exelixis and Hepion Pharmaceuticals

-0.28

Correlation Coefficient

Exelixis  Hepion Pharmaceuticals

Very good diversification

The 3 months correlation between Exelixis and Hepion is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Exelixis i.e., Exelixis and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Exelixis and Hepion Pharmaceuticals

Given the investment horizon of 90 days Exelixis is expected to generate 0.45 times more return on investment than Hepion Pharmaceuticals. However, Exelixis is 2.23 times less risky than Hepion Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest  2,583  in Exelixis on September 3, 2024 and sell it today you would earn a total of  1,063  from holding Exelixis or generate 41.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Exelixis  vs.  Hepion Pharmaceuticals

Exelixis

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Exelixis and Hepion Pharmaceuticals

The main advantage of trading using opposite Exelixis and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.

The idea behind Exelixis and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.